Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters

被引:41
作者
Gu, Y. [1 ]
Wang, G. -J. [1 ]
Wu, X. -L. [1 ]
Zheng, Y. -T. [1 ]
Zhang, J. -W. [1 ]
Ai, H. [1 ]
Sun, J. -G. [1 ]
Jia, Y. -W. [1 ]
机构
[1] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China
关键词
Ginsenoside Rh2; Intestinal Absorption; Transport; Caco-2; cells; ABC transporters; Stereoselectivity; CACO-2 CELL MONOLAYERS; P-GLYCOPROTEIN; DRUG ABSORPTION; IN-VITRO; CANCER; RH-2; RATS; PROLIFERATION; CONSTITUENTS; CYTOTOXICITY;
D O I
10.3109/00498254.2010.500744
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. This study investigated the absorption mechanism of ginsenoside Rh2 to clarify the reasons for its poor absorption. Transepithelial transport across Caco-2 cell monolayers, cellular uptake, and in situ rat intestinal perfusion were examined. 2. Cellular uptake of Rh2 was linear from 1 to 50 mu M at 4 degrees C, whereas it was saturated when the concentration exceeded 10 mu M at 37 degrees C. At 37 degrees C, the uptake at 10 mu M was linear in 60 min. Intracellular exposure in 240 min was 2173.70 and 979.38 ng . min/mu g for S and R isomers, respectively. 3. Transepithelial permeability of Rh2 was about 10(-8) to 10(-7) cm/s. Efflux ratios were above 1.5. Sodium dodecyl sulfate, sodium citrate, and sodium deoxycholate had no effect on Rh2 permeability. 4. After intestinal perfusion for 3 h, 9.1% of 20(R)- Rh2 and 15.7% of 20(S)- Rh2 were absorbed. 5. Cyclosporine, quercetin, and probenecid could improve the cellular uptake, absorptive permeability, and intestinal absorption. Carrier-mediated transport was the major absorption mechanism. Rh2 was a substrate of ABC transporters. 6. The ABC-transporter-mediated efflux and the poor permeability were the major reasons for Rh2 poor absorption. 7. The stereoselective absorption was significant. R isomer exhibited lower absorption profiles in all the experiments, possibly due to more potent efflux.
引用
收藏
页码:602 / 612
页数:11
相关论文
共 57 条
[1]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[2]   Ginseng pharmacology - Multiple constituents and multiple actions [J].
Attele, AS ;
Wu, JA ;
Yuan, CS .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) :1685-1693
[3]   Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models [J].
Bae, Eun-Ah ;
Han, Nlyung Joo ;
Shin, Yong-Wook ;
Kim, Dong-Hyun .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (09) :1862-1867
[4]   Apical sodium dependent bile acid transporter (ASBT, SLC10A2): A potential prodrug target [J].
Balakrishnan, Anand ;
Polli, James E. .
MOLECULAR PHARMACEUTICS, 2006, 3 (03) :223-230
[5]   Drug disposition in three dimensions: An update on stereoselectivity in pharmacokinetics [J].
Brocks, Dion R. .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2006, 27 (08) :387-406
[6]   Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: Impact on drug disposition and discovery [J].
Calcagno, Anna Maria ;
Ludwig, Joseph A. ;
Fostel, Jennifer M. ;
Gottesman, Michael M. ;
Ambudkar, Suresh V. .
MOLECULAR PHARMACEUTICS, 2006, 3 (01) :87-93
[7]   Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells [J].
Cheng, CC ;
Yang, SM ;
Huang, CY ;
Chen, JC ;
Chang, WM ;
Hsu, SL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (06) :531-540
[8]   A MODEL OF HUMAN SMALL INTESTINAL ABSORPTIVE CELLS .1. TRANSPORT BARRIER [J].
COGBURN, JN ;
DONOVAN, MG ;
SCHASTEEN, CS .
PHARMACEUTICAL RESEARCH, 1991, 8 (02) :210-216
[9]  
Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866
[10]   ABSORPTION OF PROGABIDE FROM AQUEOUS-SOLUTIONS IN A MODIFIED RECIRCULATING RAT INTESTINAL PERFUSION SYSTEM [J].
FARRAJ, NF ;
DAVIS, SS ;
PARR, GD ;
STEVENS, HNE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 43 (1-2) :93-100